Cary v. Delaware Secretary of State ( 2022 )


Menu:
  •       IN THE SUPERIOR COURT OF THE STATE OF DELAWARE
    DAMON CARY,                                )
    )
    Appellant,                          )
    )
    v.                            )
    )   C.A. No. N21A-02-002 CLS
    DELAWARE SECRETARY OF                      )
    STATE, JEFFERY W. BULLOCK, in              )
    his official capacity                      )
    )
    Appellee.                           )
    )
    Date Submitted: February 11, 2022
    Date Decided: March 28, 2022
    Upon Appellant’s Appeal from a Final Order of the Secretary of State.
    AFFIRMED.
    ORDER
    Michele D. Allen, Esquire, and Emily A. Biffen, Esquire, Allen & Associates
    Wilmington, DE, 19805, Attorneys for Appellant.
    Zoe Plerhoples, Esquire, Delaware Department of Justice, Wilmington, Delaware,
    19801, Attorney for Appellee, State of Delaware, Delaware Board of Medical
    Licensure and Discipline.
    SCOTT, J.
    1
    INTRODUCTION
    The Delaware Controlled Substance Advisory Committee (“CSAC”)
    recommended to the Delaware Secretary of State (“Secretary”), based on a Hearing
    Officer’s findings that Appellant’s, physician Damon D. Cary, D.O., (“Dr. Cary”),
    Controlled Substance Registration (“CSR”) be suspended for one year and imposing
    a three-year probationary period after the suspension.        The suspension and
    subsequent probation were to start on the date the Secretary signed the Final Order.
    The Secretary adopted the CSAC’s recommendation and executed the Final Order
    with explanation for adoption on January 11, 2021. Dr. Cary now appeals the Final
    Order executed by the Secretary.
    LEGISLATIVE HISTORY AND STANDARD OF REVIEW
    The Appellee here is Jeffrey W. Bullock, in his official capacity as the
    Secretary.     The Delaware General Assembly has charged the Secretary with
    regulating the registration and control of the manufacture, distribution and
    dispensing of controlled substances within Delaware.1 In order to lawfully write
    prescriptions for controlled substances, Delaware physicians must obtain a CSR
    from the Secretary.2 The Secretary, after due notice and a hearing, may limit,
    1
    16 Del. C. § 4731.
    2
    16 Del. C. § 4733.
    2
    suspend, fine, or revoke the registration of any prescriber who has violated certain
    statutory requirements.
    Following the enactment of HB 459 by the 145th General Assembly in 2010,
    a new administrative hearing process was created whereby a division hearing officer
    could conduct physicians’ disciplinary hearings.3 Pursuant to the newly enacted
    statute, hearing officers are empowered to:
    ... conduct hearings, including any evidentiary hearings. The testimony or
    evidence so taken or received shall have the same force and effect as if taken
    or received by the board or commission. Upon completion of such hearing or
    the taking of such testimony and evidence, the hearing officer shall submit to
    the board or commission findings and recommendations thereon. The findings
    of fact made by a hearing officer on a complaint are binding upon the board
    or commission. The board or commission may not consider additional
    evidence. When the proposed order is submitted to the board or commission,
    a copy shall be delivered to each of the other parties, who shall have 20 days
    to submit written exceptions, comments and arguments concerning the
    conclusions of law and recommended penalty. The board or commission shall
    3
    29 Del C. § 8735(v)(l)a; 77 Del. Laws, c. 325, §§ 23-26 (2010).
    3
    make its final decision to affirm or modify the hearing officer’s recommended
    conclusions of law and proposed sanctions based upon the written record.4
    Three years later, the Secretary’s enabling statute regarding his regulation of
    controlled substance registrants was also amended, making clear that investigations
    would be conducted by a division pursuant to the same statute, and that hearings
    involving the discipline of controlled substance registrants would be conducted
    pursuant to the Delaware Administrative Procedures Act (“APA”).5
    From the enabling legislation, the Secretary is bound by the Hearing Officer’s
    findings of fact and could not receive additional evidence. However, the Secretary
    could – and in fact did in this case – reject modify or affirm the Hearing Officer’s
    conclusions of law and recommended sanctions.
    This Court has the jurisdiction to entertain an appeal from final administrative
    orders of the Secretary under the APA.6 On appeal from the Secretary’s Orders, the
    Court must determine whether the decision is supported by “substantial evidence”
    and the agency “made no errors of law.”7 Substantial evidence is “such relevant
    4
    29 Del. C. § 8735(v)(l)d.
    5
    16 Del C. §§ 4735(a) & 4736(a); 79 Del. Laws, c. 164, § 1 (2013).
    6
    16 Del. C. § 4736(b); 29 Del. C. §§ 10102(4) & 10142(a).
    7
    29 Del. C. § 10142(d); Sekyi v. Del. Bd. of Pharmacy, 
    2018 WL 4177544
    , at *3
    (Del. Super. Aug. 29, 2018); Tri-State Liquor Mart, Ltd. v. Del. Alcoholic
    Beverage Control Comm’n, 
    1995 WL 656872
    , at *2 (Del. Super. Oct. 2, 1995).
    4
    evidence as a reasonable mind might accept as adequate to support a conclusion.”8
    The Court must review the record in a manner “most favorable to the prevailing
    party below;”9 i.e., the Secretary. The Court has neither weighed the evidence itself
    nor made its own factual findings; rather, the Court has carefully reviewed the record
    to determine whether the evidence therein is adequate to support the Secretary’s
    factual findings.10
    The Court has also carefully reviewed the record to determine whether the
    Secretary could have “fairly and reasonably” reached their conclusions. 11 “It is a
    low standard to affirm and a high standard to overturn.”12 If the findings and
    conclusions are found to be based upon substantial evidence and there is no error of
    law, the decision must be affirmed.13
    For the reasons set forth below, the Court finds, based on the record before it,
    the Secretary’s decision to temporarily revoke Dr. Cary’s CSR and subsequently
    8
    Sekyi, 
    2018 WL 4177544
    , at *3 (quoting Anchor Motor Freight v. Ciabattaoni,
    716 A2d 154, 156 (Del. 1998)).
    9
    Sekyi, 
    2018 WL 4177544
    , at *3 (quoting Bermudez v. PTFE Compounds, Inc.,
    
    2006 WL 2382793
    , at *3 (Del. Super. Aug 16, 2006)); Gaskill v. State, 
    2018 WL 3213782
    , at *1 (Del. Super. Jun. 29, 2018).
    10
    Johnson v. Chrysler Corp., 
    213 A.2d 64
    , 66 (Del. 1965).
    11
    Sekyi, 
    2018 WL 4177544
    , at *3 (citing Nat’l Cash Register v. Riner, 
    424 A.2d 669
    , 674-75 (Del. Super. 1980)).
    12
    Rooney v. Del. Bd. of Chiropractic, 
    2011 WL 2088111
    , at *3 (Del. Super. Apr.
    27, 2011).
    13
    Sokoloff v. Bd. of Med. Practice, 
    2010 WL 5550692
    , at *5 (Del. Super. Aug. 25,
    2010).
    5
    apply a probationary period are based upon substantial evidence and free from legal
    error.
    FACTUAL FINDINGS
    As discussed above, the Secretary was bound by the facts as determined by
    the Hearing Officer, and this Court is bound by the facts as determined by the
    Secretary, so long as the evidence of record is adequate to support those facts and
    the Secretary has fairly and reasonably reached their conclusions. The Court will
    briefly state the facts of record the Court has considered, utilizing these standards.
    In October of 2018, the Delaware Department of Justice (“DOJ”) filed
    disciplinary complaints against Appellant, Dr. Cary, a Board-licensed Delaware
    physician, and controlled substances registrant since 2015, with the Secretary and
    the Secretary’s designee, CSAC. The DOJ complaint alleged Dr. Cary had violated
    multiple statutes contained in the Delaware Uniform Controlled Substance Act
    (“DUCSA”). Dr. Cary’s CSR was suspended until he could be heard on the matter.
    Dr. Cary subsequent agreed to delay his hearing from September 2019 to January
    2020.
    After a hearing, on September 23, 2020, the Hearing Officer issued a 200+
    page Recommendation, with his findings of facts and conclusions of law specifically
    detailing multiple patient experiences, statutory violations, and repeated behavior.
    The CSAC utilized this Recommendation in its September 2020 deliberations and
    6
    gave Dr. Cary had the opportunity to be heard by allowing him to file written
    objections to the findings or recommendations made by the Hearing Officer. CSAC
    adopted all the findings of fact from the Hearing Officer’s report however, it
    recommended a more severe discipline than that of the Hearing Officer. CSAC
    found the Hearing Officer’s recommendations were insufficient to protect the public
    from the risk posed by Dr. Cary. On January 11, 2021, the Secretary, having
    received CSAC’s recommendation, entered a Final Order adopting the
    recommendations from CSAC, finding that Appellant violated the DUCSA and the
    controlled substance regulations. The following is a non-exhaustive list of the facts
    upon which the Secretary relied, and which supported the Order:
    • Dr. Cary never engaged in risk benefit discussions, never utilized any risk
    mitigation tools, never requested prior records, and failed to drug screen either
    undercover officer.
    • Dr. Cary increased medication for the cooperating patient without
    documenting any medical justification.
    • Dr. Cary prescribed to patient R.B. without prior treatment records and
    switched him to Percocet, which he received on at least one occasion with no
    office visit, and R.B. was subsequently arrested for selling Percocet on the
    street.
    7
    • Dr. Cary prescribed to patient E.M. without checking the PMP or performing
    a drug screen, prescribed benzodiazepines to E.M. without documented
    medical justification, and did not discuss the risks of concurrent opioid and
    benzodiazepine prescriptions to E.M.
    • Patients C.R. and S.G. had multiple inconsistent urine drug screens over the
    entire course of their treatment with Dr. Cary and he never documented any
    substantive discussion of those screens or changed his prescribing to minimize
    the risk of diversion or medication abuse.
    • Patient D.B. tested positive for unprescribed medications, including
    methamphetamines and morphine, on multiple occasions, and Dr. Cary
    continued to prescribe to him until he ultimately tested positive for heroin.
    PARTIES CONTENTIONS
    Dr. Cary argues the Hearings Officer’s recommendations and the Secretary’s
    Final Order were substantially denied beyond the statutory requirements and
    therefore were a result of legal error. Dr. Cary contends he was denied due process
    as in the hearing before the hearing officer, he was improperly denied right to present
    evidence and testimony. Additionally, he believes expert testifying against him was
    improperly allowed to testify. Dr. Cary would like this Court to reverse the January
    11, 2021 Order and impose the conditions set forth in Chief Hearing Officer of the
    Board’s July 24, 2020 Order. Dr. Cary also contends the Secretary was required to
    8
    serve him with a written order suspending his CSR no more than 30 days after the
    hearing citing Administrative Procedures of 29 Del. C. § 10128 (f).
    The State of Delaware, on behalf of the Secretary, argues Administrative
    Procedures of 29 Del. Code § 10128 (f) does not apply to the Secretary, the CSAC
    nor the Hearing Officer because the Secretary and CSAC are not listed under the
    specific State agencies which are subject to the rule. Additionally, the State argues
    Dr. Cary may not raise his issues regarding substantial delay before the hearing
    officer of the Board because he did not properly raise this when Dr. Cary was asked
    for his written exceptions to the findings of the hearing officer. On the issue of Due
    Process violation throughout the proceedings, the State contends the hearing process
    afforded Dr. Cary with the opportunity to be heard and present testimony on his
    behalf.
    ANALYSIS
    This Court need only focus on the Final Order from the Secretary of State as
    the Court may not consider appellate issues not properly brought before it. Any
    argument regarding the objection to evidence relied on or findings of the Hearing
    Officer are not properly brought before this Court as Dr. Cary had the opportunity
    to be heard on those issues when he was before the CSAC. Additionally, the
    argument of substantial delay is similarly improper. Dr. Cary may not raise his
    issues regarding substantial delay because he did not properly raise this when he was
    9
    asked for his written exceptions to the findings of the hearing officer as to correct
    the record before the CSAC hear his case. Additionally, Dr. Cary agreed to delay
    his hearing for four months and this decision tolled his suspension until the
    proceedings concluded.14 Similarly, Dr. Cary’s argument regarding the Secretary
    was required to serve him with a written order suspending his CSR no more than 30
    days after the hearing citing Administrative Procedures of 29 Del. C. § 10128 (f) is
    displaced as APA § 10161(a) provides the specific agencies the APA applies to,
    none of which include the Secretary nor the CSAC.
    There was substantial evidence to support the Secretary of State’s findings
    and enhanced penalty.
    According to the Secretary’s Final Order and statutory law, the Secretary is
    bound by the findings of fact made by the Hearing Officer and may consult with
    CSAC and require CSAC to review the Hearing Officers recommendation before
    issuing an order. In this case, CSAC reviewed written submissions of the parties
    and verbal exceptions presented during CSAC’s hearing with Dr. Cary, affording
    him the opportunity to be heard on the findings it is bound by. CSAC accepted and
    adopted the recommended conclusions of law of the Hearing Officer. However,
    CSAC recommended a one-year suspension of Dr. Cary’s CSR and three-year
    probation following the suspension, a more severe punishment than the Hearing
    14
    16 Del. C. § 4737.
    10
    Officer’s recommendation, because the Hearing Officer’s recommendation did not
    protect the public from the risk posed by Dr. Cary.       The Secretary relying, like
    CSAC, on the Hearing Officers findings of fact which outlined a pattern of
    concerning behavior including, but not limited to, not making use of urine drug
    screens, not documenting non-complying patients, giving prescriptions to non-
    complying patients without an office visit, and failure to discuss risks and benefits
    of opioids/benzodiazepines.     The pattern of behavior exhibited by Dr. Cary is
    supported by substantial evidence as provided in the Hearing Officer’s 200+ page
    report. Therefore, the Secretary’s decision to adopt the same disciplinary action as
    recommended by the board is based on substantial evidence.
    Additionally, Dr. Cary asserts the Secretary imposed sanctions (revocation of
    his CSR for one year and three-year probationary period following reinstatement)
    which are far more severe than those warranted by the facts, and which resulted at
    least in part from the Secretary’s consideration of evidence improperly contained in
    the Hearing Officer’s recommendations.
    The choice of a sanction by an administrative agency, if based on substantial
    evidence and not outside its statutory authority, is a matter of discretion to be
    exercised solely by the agency. In reviewing for an abuse of discretion, the question
    is not whether the Court would have imposed these sanctions, but whether such
    sanctions are so disproportionate to the allegations in light of all the facts as to be
    11
    “shocking to one's sense of fairness.”15 This Court finds the sanctions are not
    disproportionate to the allegations to shock one’s sense of fairness. The Court defers
    to the expertise and discretion of the Secretary.
    CONCLUSION
    The Secretary’s Final Order is supported by substantial evidence. The Court
    finds there is no error of law. Therefore, the Secretary’s Final Order is AFFIRMED.
    IT IS SO ORDERED.
    /s/ Calvin L. Scott
    Judge Calvin L. Scott, Jr.
    15
    Warmouth v. Del. State Bd. of Examiners in Optometry, 
    514 A.2d 1119
    , 1123
    (Del.Super.1985); Decker v. Del. Bd. Of Nursing, 
    2013 WL 5952103
     (Del. Super.
    Nov. 7, 2013).
    12
    

Document Info

Docket Number: N21A-02-002 CLS

Judges: Scott J.

Filed Date: 3/28/2022

Precedential Status: Precedential

Modified Date: 3/30/2022